Advanced Search
Contact | Corporate | Help

Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLC

Sponsors:
  • Accelerated Community Oncology Research Network
  • Eli Lilly and Company
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Non-small Cell Lung Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Pemetrexed and Gemcitabine plus Bevacizumab
Enrollment:
48

Additional information about NCT00517595.


SourceSolution © 2008-2012